Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience

Stanford University Medical Center, Division of Blood and Marrow Transplantation, Stanford, California 94305, USA.
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation (Impact Factor: 3.35). 08/2008; 14(7):741-7. DOI: 10.1016/j.bbmt.2008.04.004
Source: PubMed

ABSTRACT The peripheral T cell lymphomas (PTCL) carry a worse prognosis compared to B cell non-Hodgkin lymphoma. There is no uniform standard therapy for PTCL, and autologous hematopoietic cell transplant (AHCT) is often offered as consolidation in first remission or at relapse because of the poor outcomes with conventional therapy. We conducted a retrospective review of patients who underwent AHCT for PTCL from 1989 to 2006. Fifty-three cases were identified consisting of systemic anaplastic large cell (n = 18), PTCL unspecified (n = 17), angioimmunoblastic (n = 9), nasal type extranodal NK/T (n = 7), hepatosplenic (n = 2), and adult T cell leukemia/lymphoma (n = 1). Fifteen patients were transplanted in first complete or partial response (CR1/PR1), 32 in second or beyond CR or PR (CR2/PR2+), and 11 with primary refractory disease (REF). With a median follow-up was 5 years (range: 1.0-11.5), the 5-year progression-free survival (PFS) and overall survival (OS) were 25% and 48%, respectively. Disease status at AHCT had a significant impact on PFS and OS. The 5-year PFS for patients in CR1/PR1, CR2/PR2+, and REF was 51%, 12%, and 0%, respectively, and the corresponding figures for OS were 76%, 40%, and 30%, respectively. The pretransplant factors that impacted survival were disease status and the number of prior regimens. Histology, age, sex, stage, B symptoms, bone marrow involvement, and duration of first response did not significantly affect PFS or OS. Based on these results, AHCT as consolidation therapy in first complete or partial response may offer a durable survival benefit. However, AHCT with conventional salvage chemotherapy has minimal durable benefit in patients with relapsed or refractory PTCL, and thus novel strategies and/or allogeneic HCT should be more aggressively explored in lieu of AHCT for relapsed/ refractory PTCL.

Download full-text


Available from: Alex Mcmillan, May 26, 2015
  • Source
    • "In these reports, firstline therapy produced disease-free survival rates with long follow-up of 30–40% (Mercadal et al, 2008; Reimer et al, 2009). Progression-free survival rates for auto-SCT in patients with second remission or refractory disease were reported to be 0% and 15–20% (Rodríguez et al, 2007b; Chen et al, 2008). Reports of experience with allogeneic SCT in non-anaplastic PTCL are similarly limited. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Reports of non-anaplastic peripheral T-cell lymphoma (PTCL) in paediatric patients, especially results of stem cell transplantation (SCT), are relatively rare. We herein report the results of SCT using the Transplant Registry Unified Management Program system of the Japanese Society of Stem Cell Transplantation in paediatric patients with non-anaplastic PTCL. We analysed 26 patients (13 females and 13 males) aged ≤18 years with non-anaplastic PTCL who underwent a total of 28 SCT. Median age at transplantation was 13·5 years (range: 0-18 years). PTCL not otherwise specified was diagnosed in 17 patients; extranodal Natural Killer (NK)/T cell lymphoma, nasal type in nine; and subcutaneous panniculitis-like T-cell lymphoma in two. Transplantation was with syngeneic donor in one, related donor in 10; unrelated donor in 10; and auto transplantation in 7. Five-year overall survival rate and event-free survival rate was 62·96% and 55·56%, respectively. Male gender, chronic graft-versus-host disease (GVHD), and reduced intensity conditioning were good prognostic factors in all patients. In 20 patients with refractory or relapsed disease, male gender and chronic GVHD were also good prognostic factors. This study is the first report concerning transplantation in children with non-anaplastic PTCL, although the number of patients was small. Larger studies are needed to confirm these findings.
    British Journal of Haematology 08/2012; 159(1):88-93. DOI:10.1111/bjh.12001 · 4.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The general chemotherapy for Peripheral T-cell lymphoma (PTCL) featuring an active invasion has less curative effect and worse prognosis in comparison with that for B-cell non-Hodgkin’s lymphoma (NHL). Studies in recent years suggest that hematopoietic stem cell transplantation (HSCT) has better curative effect on the PTCL; however, it is significant to do more studies on some aspects such as the methodology, punctuality, preconditioning, and pretreatment intensity of the transplantation, which are crucial to the curative effect. Key wordshematopoietic stem cell transplantation (HSCT)–peripheral T-cell lymphoma (PTCL)–progress
    The Chinese-German Journal of Clinical Oncology 05/2011; 10(5):293-296. DOI:10.1007/s10330-011-0779-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vibrating beam structures may be used as sensing elements in an angular rate measurement sensor. Achieving a square cross-sectional area with smooth vertical side walls and sharp edges is necessary for these beams. In this work, fabrication of beams with reasonably smooth vertical sidewalls and accurate dimensions, using anisotropic etching of silicon in TMAH, has been investigated. Beams with various thicknesses (500-100 microns) are fabricated. It is shown that by carefully aligning the mask at 45° from the 〈110〉 wafer flat, and by maintaining the concentration of TMAH at 25%, it is possible to achieve smooth vertical sidewalls with good uniformity along the length of the beam. Adequate control over the beam lateral dimension is achieved by etching in a 2-step procedure with the second step at a lower temperature (lower etch rate). Single-sided and double-sided masking techniques are investigated in order to fabricate the beams. An alternative design is presented to form the beams using a standard CMOS process
    Electrical and Computer Engineering, 1996. Canadian Conference on; 06/1996
Show more